African Oncogenetics Network: improving training and infrastructure in low-resource regions

Hammamet Declaration on Oncogenetics in Africa: African Oncogenetics Network

The aims of the African Oncogenetics Network

MRD validated as a surrogate endpoint for survival in AML

IP6K1-driven tumour polyphosphate may contribute to immune checkpoint inhibitor-associated thrombosis

Exploring genomic insights in acute lymphoblastic leukaemia treatment

AI-Based sTIL analysis expands identification of HER2+ BC patients benefiting from pertuzumab

New genomic map of adult B-ALL identifies CEBPalt subgroup and highlights blinatumomab benefits in key high-risk molecular types

Empowering cancer care in Africa

Do all hormone sensitive prostate cancers need triplet therapy?

Molecular assay may help identify NSCLC patients who could benefit from adjuvant chemotherapy

Insights into germline genetic screening of breast cancer patients